StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Rekah Pharmaceutical Industry Ltd.
Tel Aviv Stock Exchange:REKA.TA
Sector
Location
Market Cap
USD 43.90 M
Share Price
USD 3.85
Avg Daily Volume
3,644
Change (1 day)
-1.44%
Change (1 year)
5.21%
Change (YTD)
4.57%
Rekah Pharmaceutical Industry Ltd. Total Assets for the year ending December 31, 2024: USD 122.74 M
Rekah Pharmaceutical Industry Ltd. Total Assets is USD 122.74 M for the year ending December 31, 2024, a -8.06% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
-
Rekah Pharmaceutical Industry Ltd. Total Assets for the year ending December 31, 2023 was USD 133.50 M, a 4.76% change year over year.
-
Rekah Pharmaceutical Industry Ltd. Total Assets for the year ending December 31, 2022 was USD 127.43 M, a -9.41% change year over year.
-
Rekah Pharmaceutical Industry Ltd. Total Assets for the year ending December 31, 2021 was USD 140.66 M, a 7.76% change year over year.
-
Rekah Pharmaceutical Industry Ltd. Total Assets for the year ending December 31, 2020 was USD 130.53 M, a 23.02% change year over year.
Competitors
Johnson & Johnson
USD 156.01
JNJ
+0.45
0.29%
Divi's Laboratories Limited
USD 80.76
DIVISLAB.NS
+0.23
0.29%
ALK-Abelló A/S
USD 29.32
ALK-B.CO
+0.00
0.01%
Nahdi Medical Company
USD 34.75
4164.SR
+0.53
1.56%
Rohto Pharmaceutical Co.,Ltd.
USD 14.21
4527.T
-0.03
-0.20%
Hypera S.A.
USD 5.07
HYPE3.SA
+0.03
0.51%
J. B. Chemicals & Pharmaceuticals Limited
USD 19.22
JBCHEPHARM.NS
+0.02
0.09%
Almirall, S.A.
USD 12.49
ALM.MC
-0.02
-0.17%
Organon & Co.
USD 9.96
OGN
-0.19
-1.87%
Dermapharm Holding SE
USD 41.44
DMP.DE
+0.15
0.36%
Caplin Point Laboratories Limited
USD 23.49
CAPLIPOINT.NS
+0.04
0.16%
Eli Lilly and Company
USD 780.10
LLY
+0.82
0.10%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Key Data
| Date | Total Assets | Accounts Payable | Short-Term Debt | Long-Term Debt |
|---|
Competitors
Johnson & Johnson
USD 156.01
JNJ
+0.45
0.29%
Divi's Laboratories Limited
USD 80.76
DIVISLAB.NS
+0.23
0.29%
ALK-Abelló A/S
USD 29.32
ALK-B.CO
+0.00
0.01%
Nahdi Medical Company
USD 34.75
4164.SR
+0.53
1.56%
Rohto Pharmaceutical Co.,Ltd.
USD 14.21
4527.T
-0.03
-0.20%
Hypera S.A.
USD 5.07
HYPE3.SA
+0.03
0.51%
J. B. Chemicals & Pharmaceuticals Limited
USD 19.22
JBCHEPHARM.NS
+0.02
0.09%
Almirall, S.A.
USD 12.49
ALM.MC
-0.02
-0.17%
Organon & Co.
USD 9.96
OGN
-0.19
-1.87%
Dermapharm Holding SE
USD 41.44
DMP.DE
+0.15
0.36%
Caplin Point Laboratories Limited
USD 23.49
CAPLIPOINT.NS
+0.04
0.16%
Eli Lilly and Company
USD 780.10
LLY
+0.82
0.10%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%